4//SEC Filing
DAVIS A BRIAN 4
Accession 0001209191-20-046962
CIK 0001660334other
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 4:38 PM ET
Size
5.1 KB
Accession
0001209191-20-046962
Insider Transaction Report
Form 4
DAVIS A BRIAN
Chief Financial Officer
Transactions
- Purchase
Common Stock
2020-08-13$6.24/sh+7,900$49,296→ 7,900 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.19 to $6.27 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Documents
Issuer
Verrica Pharmaceuticals Inc.
CIK 0001660334
Entity typeother
Related Parties
1- filerCIK 0001184432
Filing Metadata
- Form type
- 4
- Filed
- Aug 16, 8:00 PM ET
- Accepted
- Aug 17, 4:38 PM ET
- Size
- 5.1 KB